CNIPA.AI
返回搜索
档案

THRESHOLD-STIMULATED PLASMA KALLIKREIN ACTIVITY AS A BIOMARKER FOR DIAGNOSIS OF BRADYKININ-MEDIATED ANGIOEDEMA

发明专利审中
3浏览
7权利要求 · 1 独立
§ Ⅰ

卷宗概要

发明人

Bruce Zuraw; Maria Luz Lara-Marquez

IPC 分类

C12Q 1/37C12Q 1/2

CPC 分类

C12Q1/37C12Q1/2C12Q2600/112

Provided is a diagnostic test for the positive identification of patients with bradykinin-mediated angioedema. The test is valuable for distinguishing bradykinin-mediated angioedema from non-bradykinin-mediated angioedema. The test allows clinicians to clearly separate patients with bradykinin-mediated from histamine-mediated angioedema. Results can be obtained in under an hour, allowing for the proper treatment of angioedema based on the underlying etiology.

原文(中文)

Provided is a diagnostic test for the positive identification of patients with bradykinin-mediated angioedema. The test is valuable for distinguishing bradykinin-mediated angioedema from non-bradykinin-mediated angioedema. The test allows clinicians to clearly separate patients with bradykinin-mediated from histamine-mediated angioedema. Results can be obtained in under an hour, allowing for the proper treatment of angioedema based on the underlying etiology.